Cargando…
Gene Therapy for Parkinson’s Disease, An Update
The current mainstay treatment of Parkinson’s disease (PD) consists of dopamine replacement therapy which, in addition to causing several side effects, does not delay disease progression. The field of gene therapy offers a potential means to improve current therapy. The present review gives an updat...
Autores principales: | Axelsen, Tobias M., Woldbye, David P.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027861/ https://www.ncbi.nlm.nih.gov/pubmed/29710735 http://dx.doi.org/10.3233/JPD-181331 |
Ejemplares similares
-
Disease Modification by Combinatorial Single Vector Gene Therapy: A Preclinical Translational Study in Epilepsy
por: Melin, Esbjörn, et al.
Publicado: (2019) -
An Update on Gene Therapy Approaches for Parkinson’s Disease: Restoration of Dopaminergic Function
por: Van Laar, Amber D., et al.
Publicado: (2021) -
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
por: Jensen, Thomas Leth, et al.
Publicado: (2021) -
An update on advanced therapies for Parkinson's disease: From gene therapy to neuromodulation
por: Serva, Stephanie N., et al.
Publicado: (2022) -
Parkinson Disease Psychosis: Update
por: Friedman, J. H.
Publicado: (2013)